Latest news
Analysis of Factors of Subcutaneous Blister Formation in the Continuous Cast Billets Based on the Limited Sample - Springer Nature LinkSpringer Nature Link · Fri, 07 Aug 2026 19:22:55 GMTAlteogen Signs Up to $365 Million Hybrozyme Licensing Deal for Subcutaneous Biologic - BioPharma APACBioPharma APAC · Fri, 07 Aug 2026 01:06:22 GMTAlteogen Licenses Subcutaneous Platform to Undisclosed Global Pharma Company in Deal Worth Up to $365 Million - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:10:58 GMTAlteogen Inks Licensing Pact with Global Pharma Company to Develop, Commercialize Subcutaneous Biologic - Contract PharmaContract Pharma · Wed, 05 Aug 2026 15:57:30 GMTForlong advances IL-15 superagonist into Australian Phase I trial with subcutaneous dosing - AllSciAllSci · Wed, 05 Aug 2026 10:31:21 GMTSubcutaneous Amivantamab Receives FDA Priority Review in R/M HNSCC - CancerNetworkCancerNetwork · Fri, 31 Jul 2026 17:08:12 GMTSubcutaneous Zygomycosis Successfully Treated With Itraconazole Monotherapy: A Case Report From Central India - CureusCureus · Fri, 31 Jul 2026 04:40:07 GMTFDA Grants Priority Review to Subcutaneous Amivantamab in Head and Neck Cancer - OncLiveOncLive · Thu, 30 Jul 2026 07:00:00 GMT